U
HTG Molecular Diagnostics, Inc. HTGMQ
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income 22.20% 9.61% -0.57% -125.17% -34.02%
Total Depreciation and Amortization -53.58% -34.60% -30.67% -5.41% -6.31%
Total Amortization of Deferred Charges -39.00% -29.53% -12.58% -2.06% -4.31%
Total Other Non-Cash Items 69.79% 132.36% -61.97% 133.27% -38.31%
Change in Net Operating Assets -8.63% 22.43% 4.23% 28.44% 67.45%
Cash from Operations 26.53% 40.32% -8.99% -28.59% -36.44%
Capital Expenditure 26.19% 100.00% 96.56% 98.11% 91.47%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -165.53% 15.76% 403.99% 80.37% 301.03%
Cash from Investing -165.74% 17.98% 687.68% 80.72% 293.62%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 42.86% -400.91% -1,382.75% -1,433.52% -726.86%
Issuance of Common Stock -- 2,336.44% -- -- 7.82%
Repurchase of Common Stock 97.53% 42.86% -5,714.29% -72,714.29% -575.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 18.64% 33.60% 9.40% 171.24% -72.24%
Cash from Financing -123.54% 23,085.67% -1,485.01% -143.09% -14.73%
Foreign Exchange rate Adjustments 208.33% 748.48% -142.59% -578.26% 62.89%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -283.76% 1,529.00% 23.98% -8.01% 908.66%
Weiss Ratings